Decision making and health policy Flashcards
What is a top up payment?
Topping up on NHS care with private care as some treatments are not available on the NHS if their efficacious or cost effective data is not available or doesn’t meet NICE criteria.
What is a top up payment?
Topping up on NHS care with private care as some treatments are not available on the NHS if their efficacious or cost effective data is not available or doesn’t meet NICE criteria.
What is the issue with top up payments?
Disrupts horizontal equity to access as it is based on wealth.
Unknown if the treatment effects will cause future costs for NHS
Can a clinician advise private treatment?
Can advocate for Pt if it is in their best interests, whilst allowing them to make an informed choice.
What are the benefits of top ups?
Benefits the Pt and gives them access to other treatments.
Saves NHS resources
If a drug is not approved by NICE, how may they appeal it?
May try to get it approved as an end of life treatment. If a population with a low life expectancy gains >3mnths of life.
Why is an independent assessor required in a technology appraisal?
To compare independent cost-effective and cost utility analysis results with those of the company to see if they are reliable and to prevent them from advocating for themselves.
When can a drug be appealed as an end of life drug?
If QoL is gained, applies only to Pts with a short life expectancy and is cost effective as an end of life treatment.
What is the QALY approval threshold by NICE?
What must a doctor consider to balance the available resources?
Consider health needs of an individual against the wider population to balance supply with demand.
What is the issue with top up payments?
Disrupts horizontal equity to access as it is based on wealth.
Unknown if the treatment effects will cause future costs for NHS
Can a clinician advise private treatment?
Can advocate for Pt if it is in their best interests, whilst allowing them to make an informed choice.
What are the benefits of top ups?
Benefits the Pt and gives them access to other treatments.
Saves NHS resources
If a drug is not approved by NICE, how may they appeal it?
May try to get it approved as an end of life treatment. If a population with a low life expectancy gains >3mnths of life.
Why is an independent assessor required in a technology appraisal?
To compare independent cost-effective and cost utility analysis results with those of the company to see if they are reliable and to prevent them from advocating for themselves.
